Covered recipient · General Payments record
PHILIP GILLY
Allopathic & Osteopathic Physicians Family Medicine Addiction Medicine
General Payments · PY2018–2024
$9,082.41
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $550.79 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $232.37 | 16 |
| ABBVIE INC. | $91.63 | 4 |
| Braeburn Inc. | $76.45 | 5 |
| Alkermes, Inc. | $66.12 | 3 |
| Orexo US, Inc. | $27.06 | 2 |
| ITI, Inc. | $23.32 | 1 |
| Janssen Pharmaceuticals, Inc | $17.32 | 1 |
| Neurocrine BioSciences, Inc. | $16.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.72 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799566 | CMS |
| ABBVIE INC. | $17.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799568 | CMS |
| ABBVIE INC. | $25.40 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799570 | CMS |
| ABBVIE INC. | $25.05 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799572 | CMS |
| Alkermes, Inc. | $27.70 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120505096 | CMS |
| Alkermes, Inc. | $16.51 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120505098 | CMS |
| Alkermes, Inc. | $21.91 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120505100 | CMS |
| Braeburn Inc. | $13.73 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125606211 | CMS |
| Braeburn Inc. | $18.76 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125606209 | CMS |
| Braeburn Inc. | $13.76 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125606213 | CMS |
| Braeburn Inc. | $13.08 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125606217 | CMS |
| Braeburn Inc. | $17.12 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125606215 | CMS |
| Indivior Inc. | $15.86 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528594 | CMS |
| Indivior Inc. | $7.85 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528596 | CMS |
| Indivior Inc. | $12.81 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528598 | CMS |
| Indivior Inc. | $15.52 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528600 | CMS |
| Indivior Inc. | $14.95 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528602 | CMS |
| Indivior Inc. | $6.75 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528604 | CMS |
| Indivior Inc. | $16.72 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528606 | CMS |
| Indivior Inc. | $21.20 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528608 | CMS |
| Indivior Inc. | $15.08 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528610 | CMS |
| Indivior Inc. | $17.44 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528612 | CMS |
| Indivior Inc. | $5.27 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528614 | CMS |
| Indivior Inc. | $16.10 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528616 | CMS |
| Indivior Inc. | $21.52 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528618 | CMS |
| Indivior Inc. | $23.20 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528620 | CMS |
| Indivior Inc. | $17.23 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528622 | CMS |
| Indivior Inc. | $4.87 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528624 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.32 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143230711 | CMS |
| Janssen Pharmaceuticals, Inc | $17.32 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078055184 | CMS |
| Neurocrine Biosciences, Inc. | $16.52 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150870545 | CMS |
| Orexo US, Inc. | $13.94 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136178046 | CMS |
| Orexo US, Inc. | $13.12 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136178048 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.